The initiative intends to track and prevent the spread of communicable, vector-borne, and water-borne diseases across the ...

After spending years unsuccessfully attempting to develop a Covid-19 vaccine, Inovio is now reporting promising results from early testing of an experimental Covid treatment.

Cut programs included funding for childhood vaccinations, COVID-era public health grants, and research on sexual and gender ...

The core of the coronavirus SARS-CoV-2 is a single strip ... One concern is that people can develop immunity to the viral vector, making this approach potentially less useful if booster shots ...

More traditional COVID vaccines (vector viral) like the one developed by Johnson & Johnson and Oxford-AstraZeneca were associated with more statistically significant increases in rare adverse ...

Whereas the Pfizer and Moderna COVID-19 vaccines suspend mRNA in lipid nanoparticles, the vaccine developed by WashU Medicine uses an adenovirus vector to deliver its payload. Adenoviruses are DNA ...

AAP FactCheck - A study of the immune patterns in vaccinated people does not show mRNA jabs are giving people AIDS, despite ...

“We were wondering whether COVID-19 symptoms and long COVID might vary by vaccine type viral vector, and protein subunit,” he noted. The researchers also were unable to assess specific ...

“While the current, needle-based COVID-19 vaccines have prevented a tremendous ... from design and biomanufacturing at McMaster’s Robert E. Fitzhenry Vector Laboratory to pre-clinical and ...